A Safety Study of Carfilzomib With Cyclophosphamide and Dexamethasone Prior to Autologous Stem Cell Transplant in Patients With Newly Diagnosed Multiple Myeloma
by on Friday, August 10th, 2012 | No Comments
Condition: Multiple Myeloma
Interventions: Drug: Carfilzomib; Drug: Cyclophosphamide; Drug: Dexamethasone
Sponsors: Academic Myeloma Consortium; Academic Myeloma Consortium; Onyx Pharmaceuticals
Not yet recruiting – verified August 2012